Pharmaceutical

Pluri’s immune cell expansion technologies gain patents

Pluri has announced the issuance of a patent by the US Patent and Trademark Office (USPTO) for its immune cell expansion technologies.

Apr 12, 2025 - 06:00
Pluri’s immune cell expansion technologies gain patents
Pluri has announced the issuance of a patent by the US Patent and Trademark Office (USPTO) for its immune cell expansion technologies.
Read the original article

Tags:

Previous Article

Novartis commits $23bn to US manufacturing amid tariff threats

Next Article

FDA to phase out animal testing with AI and lab-based models

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Coherus plans Humira biosimilar sale at 85% discount

Coherus plans Humira biosimilar sale at 85% discount

Jul 15, 2023

OMERS snaps up drug royalties and milestones from Xencor for $215m

OMERS snaps up drug royalties and milestones from Xenco...

Nov 8, 2023

Therini Bio raises funds to develop neurodegenerative disease therapies

Therini Bio raises funds to develop neurodegenerative d...

Apr 28, 2023